Global Long-Term Acute Care Market Research Report 2019

1 Study Coverage

• 1.1 Long-Term Acute Care Product Introduction
• 1.2 Market Segments
• 1.3 Key Long-Term Acute Care Manufacturers Covered: Ranking by Revenue
• 1.4 Market by Type
  • 1.4.1 Global Long-Term Acute Care Market Size Growth Rate by Type
  • 1.4.2 Blood Devices
  • 1.4.3 Oxygen Delivery Devices
  • 1.4.4 Aerosol Delivery Devices
  • 1.4.5 Advanced Wound Dressings
  • 1.4.6 Skin Substitutes
  • 1.4.7 Heart Monitors
  • 1.4.8 Other
• 1.5 Market by Application
  • 1.5.1 Global Long-Term Acute Care Market Size Growth Rate by Application
  • 1.5.2 Respiratory Patients
  • 1.5.3 Transfusions Required Patients
  • 1.5.4 Renal Failure Patients
  • 1.5.5 Prolonged Ventilator Use Patients
  • 1.5.6 Wound Care Patients
  • 1.5.7 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Long-Term Acute Care Market Size, Estimates and Forecasts
  • 2.1.1 Global Long-Term Acute Care Revenue 2015-2026
  • 2.1.2 Global Long-Term Acute Care Sales 2015-2026
• 2.2 Global Long-Term Acute Care, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.2.1 Global Long-Term Acute Care Retrospective Market Scenario in Sales by Region: 2015-2020
  • 2.2.2 Global Long-Term Acute Care Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Long-Term Acute Care Competitor Landscape by Players

• 3.1 Long-Term Acute Care Sales by Manufacturers
  • 3.1.1 Long-Term Acute Care Sales by Manufacturers (2015-2020)
  • 3.1.2 Long-Term Acute Care Sales Market Share by Manufacturers (2015-2020)
• 3.2 Long-Term Acute Care Revenue by Manufacturers
  • 3.2.1 Long-Term Acute Care Revenue by Manufacturers (2015-2020)
  • 3.2.2 Long-Term Acute Care Revenue Share by Manufacturers (2015-2020)
  • 3.2.3 Global Long-Term Acute Care Market Concentration Ratio (CR5 and HHI) (2015-2020)
  • 3.2.4 Global Top 10 and Top 5 Companies by Long-Term Acute Care Revenue in 2019
  • 3.2.5 Global Long-Term Acute Care Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Long-Term Acute Care Price by Manufacturers
• 3.4 Long-Term Acute Care Manufacturing Base Distribution, Product Types
  • 3.4.1 Long-Term Acute Care Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Long-Term Acute Care Product Type
  • 3.4.3 Date of International Manufacturers Enter into Long-Term Acute Care Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Long-Term Acute Care Market Size by Type (2015-2020)
  • 4.1.1 Global Long-Term Acute Care Sales by Type (2015-2020)
  • 4.1.2 Global Long-Term Acute Care Revenue by Type (2015-2020)
  • 4.1.3 Long-Term Acute Care Average Selling Price (ASP) by Type (2015-2026)
• 4.2 Global Long-Term Acute Care Market Size Forecast by Type (2021-2026)
  • 4.2.1 Global Long-Term Acute Care Sales Forecast by Type (2021-2026)
  • 4.2.2 Global Long-Term Acute Care Revenue Forecast by Type (2021-2026)
  • 4.2.3 Long-Term Acute Care Average Selling Price (ASP) Forecast by Type (2021-2026)
• 4.3 Global Long-Term Acute Care Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

• 5.1 Global Long-Term Acute Care Market Size by Application (2015-2020)
  • 5.1.1 Global Long-Term Acute Care Sales by Application (2015-2020)
  • 5.1.2 Global Long-Term Acute Care Revenue by Application (2015-2020)
  • 5.1.3 Long-Term Acute Care Price by Application (2015-2020)
• 5.2 Long-Term Acute Care Market Size Forecast by Application (2021-2026)
  • 5.2.1 Global Long-Term Acute Care Sales Forecast by Application (2021-2026)
  • 5.2.2 Global Long-Term Acute Care Revenue Forecast by Application (2021-2026)
  • 5.2.3 Global Long-Term Acute Care Price Forecast by Application (2021-2026)

6 North America

• 6.1 North America Long-Term Acute Care by Country
  • 6.1.1 North America Long-Term Acute Care Sales by Country
  • 6.1.2 North America Long-Term Acute Care Revenue by Country
  • 6.1.3 U.S.
  • 6.1.4 Canada
• 6.2 North America Long-Term Acute Care Market Facts & Figures by Type
• 6.3 North America Long-Term Acute Care Market Facts & Figures by Application

7 Europe

• 7.1 Europe Long-Term Acute Care by Country
  • 7.1.1 Europe Long-Term Acute Care Sales by Country
  • 7.1.2 Europe Long-Term Acute Care Revenue by Country
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 U.K.
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Long-Term Acute Care Market Facts & Figures by Type
• 7.3 Europe Long-Term Acute Care Market Facts & Figures by Application

8 Asia Pacific

• 8.1 Asia Pacific Long-Term Acute Care by Region
  • 8.1.1 Asia Pacific Long-Term Acute Care Sales by Region
  • 8.1.2 Asia Pacific Long-Term Acute Care Revenue by Region
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 South Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Taiwan
  • 8.1.9 Indonesia
  • 8.1.10 Thailand
  • 8.1.11 Malaysia
  • 8.1.12 Philippines
  • 8.1.13 Vietnam
• 8.2 Asia Pacific Long-Term Acute Care Market Facts & Figures by Type
• 8.3 Asia Pacific Long-Term Acute Care Market Facts & Figures by Application

9 Latin America

• 9.1 Latin America Long-Term Acute Care by Country
  • 9.1.1 Latin America Long-Term Acute Care Sales by Country
  • 9.1.2 Latin America Long-Term Acute Care Revenue by Country
  • 9.1.3 Mexico
  • 9.1.4 Brazil
  • 9.1.5 Argentina
• 9.2 Central & South America Long-Term Acute Care Market Facts & Figures by Type
• 9.3 Central & South America Long-Term Acute Care Market Facts & Figures by Application

10 Middle East and Africa

• 10.1 Middle East and Africa Long-Term Acute Care by Country
  • 10.1.1 Middle East and Africa Long-Term Acute Care Sales by Country
  • 10.1.2 Middle East and Africa Long-Term Acute Care Revenue by Country
  • 10.1.3 Turkey
  • 10.1.4 Saudi Arabia
  • 10.1.5 U.A.E
• 10.2 Middle East and Africa Long-Term Acute Care Market Facts & Figures by Type
• 10.3 Middle East and Africa Long-Term Acute Care Market Facts & Figures by Application

11 Company Profiles

• 11.1 Johnson & Johnson
  • 11.1.1 Johnson & Johnson Corporation Information
  • 11.1.2 Johnson & Johnson Description and Business Overview
  • 11.1.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
  • 11.1.4 Johnson & Johnson Long-Term Acute Care Products Offered
  • 11.1.5 Johnson & Johnson Related Developments
• 11.2 GE Healthcare
  • 11.2.1 GE Healthcare Corporation Information
  • 11.2.2 GE Healthcare Description and Business Overview
  • 11.2.3 GE Healthcare Sales, Revenue and Gross Margin (2015-2020)
  • 11.2.4 GE Healthcare Long-Term Acute Care Products Offered
  • 11.2.5 GE Healthcare Related Developments
• 11.3 Medtronic
  • 11.3.1 Medtronic Corporation Information
  • 11.3.2 Medtronic Description and Business Overview
  • 11.3.3 Medtronic Sales, Revenue and Gross Margin (2015-2020)
  • 11.3.4 Medtronic Long-Term Acute Care Products Offered
  • 11.3.5 Medtronic Related Developments
• 11.4 Baxter
  • 11.4.1 Baxter Corporation Information
  • 11.4.2 Baxter Description and Business Overview
  • 11.4.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
  • 11.4.4 Baxter Long-Term Acute Care Products Offered
  • 11.4.5 Baxter Related Developments
• 11.5 Fresenius Medical Care
  • 11.5.1 Fresenius Medical Care Corporation Information
  • 11.5.2 Fresenius Medical Care Description and Business Overview
  • 11.5.3 Fresenius Medical Care Sales, Revenue and Gross Margin (2015-2020)
  • 11.5.4 Fresenius Medical Care Long-Term Acute Care Products Offered
  • 11.5.5 Fresenius Medical Care Related Developments
• 11.6 Philips
  • 11.6.1 Philips Corporation Information
  • 11.6.2 Philips Description and Business Overview
  • 11.6.3 Philips Sales, Revenue and Gross Margin (2015-2020)
  • 11.6.4 Philips Long-Term Acute Care Products Offered
  • 11.6.5 Philips Related Developments
• 11.7 Cardinal Health
  • 11.7.1 Cardinal Health Corporation Information
  • 11.7.2 Cardinal Health Description and Business Overview
  • 11.7.3 Cardinal Health Sales, Revenue and Gross Margin (2015-2020)
  • 11.7.4 Cardinal Health Long-Term Acute Care Products Offered
  • 11.7.5 Cardinal Health Related Developments
• 11.8 Novartis
  • 11.8.1 Novartis Corporation Information
  • 11.8.2 Novartis Description and Business Overview
  • 11.8.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
  • 11.8.4 Novartis Long-Term Acute Care Products Offered
  • 11.8.5 Novartis Related Developments
• 11.9 Stryker
  • 11.9.1 Stryker Corporation Information
  • 11.9.2 Stryker Description and Business Overview
  • 11.9.3 Stryker Sales, Revenue and Gross Margin (2015-2020)
  • 11.9.4 Stryker Long-Term Acute Care Products Offered
  • 11.9.5 Stryker Related Developments
• 11.10 BD
  • 11.10.1 BD Corporation Information
  • 11.10.2 BD Description and Business Overview
  • 11.10.3 BD Sales, Revenue and Gross Margin (2015-2020)
  • 11.10.4 BD Long-Term Acute Care Products Offered
  • 11.10.5 BD Related Developments
• 11.1 Johnson & Johnson
  • 11.1.1 Johnson & Johnson Corporation Information
  • 11.1.2 Johnson & Johnson Description and Business Overview
  • 11.1.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
  • 11.1.4 Johnson & Johnson Long-Term Acute Care Products Offered
  • 11.1.5 Johnson & Johnson Related Developments
• 11.12 Abbott Laboratories
  • 11.12.1 Abbott Laboratories Corporation Information
  • 11.12.2 Abbott Laboratories Description and Business Overview
  • 11.12.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
  • 11.12.4 Abbott Laboratories Products Offered
  • 11.12.5 Abbott Laboratories Related Developments
• 11.13 Terumo
  • 11.13.1 Terumo Corporation Information
  • 11.13.2 Terumo Description and Business Overview
  • 11.13.3 Terumo Sales, Revenue and Gross Margin (2015-2020)
  • 11.13.4 Terumo Products Offered
  • 11.13.5 Terumo Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

• 12.1 Long-Term Acute Care Market Estimates and Projections by Region
  • 12.1.1 Global Long-Term Acute Care Sales Forecast by Regions 2021-2026
  • 12.1.2 Global Long-Term Acute Care Revenue Forecast by Regions 2021-2026
• 12.2 North America Long-Term Acute Care Market Size Forecast (2021-2026)
  • 12.2.1 North America: Long-Term Acute Care Sales Forecast (2021-2026)
  • 12.2.2 North America: Long-Term Acute Care Revenue Forecast (2021-2026)
  • 12.2.3 North America: Long-Term Acute Care Market Size Forecast by Country (2021-2026)
• 12.3 Europe Long-Term Acute Care Market Size Forecast (2021-2026)
  • 12.3.1 Europe: Long-Term Acute Care Sales Forecast (2021-2026)
  • 12.3.2 Europe: Long-Term Acute Care Revenue Forecast (2021-2026)
  • 12.3.3 Europe: Long-Term Acute Care Market Size Forecast by Country (2021-2026)
• 12.4 Asia Pacific Long-Term Acute Care Market Size Forecast (2021-2026)
  • 12.4.1 Asia Pacific: Long-Term Acute Care Sales Forecast (2021-2026)
  • 12.4.2 Asia Pacific: Long-Term Acute Care Revenue Forecast (2021-2026)
  • 12.4.3 Asia Pacific: Long-Term Acute Care Market Size Forecast by Region (2021-2026)
• 12.5 Latin America Long-Term Acute Care Market Size Forecast (2021-2026)
  • 12.5.1 Latin America: Long-Term Acute Care Sales Forecast (2021-2026)
  • 12.5.2 Latin America: Long-Term Acute Care Revenue Forecast (2021-2026)
  • 12.5.3 Latin America: Long-Term Acute Care Market Size Forecast by Country (2021-2026)
• 12.6 Middle East and Africa Long-Term Acute Care Market Size Forecast (2021-2026)
  • 12.6.1 Middle East and Africa: Long-Term Acute Care Sales Forecast (2021-2026)
  • 12.6.2 Middle East and Africa: Long-Term Acute Care Revenue Forecast (2021-2026)
  • 12.6.3 Middle East and Africa: Long-Term Acute Care Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Porter's Five Forces Analysis
• 13.5 Primary Interviews with Key Long-Term Acute Care Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Long-Term Acute Care Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details